Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The Journal of Rheumatology|February 9, 2018
Barriers to Adherence in Juvenile Idiopathic Arthritis: A Multicenter Collaborative Experience and Preliminary ResultsLeslie A Favier, Janalee Taylor, Kristin Loiselle Rich, et al.
Children (Basel, Switzerland)|December 30, 2025
A Canadian Advanced Physiotherapist Practitioner Shared-Care Model in Pediatric Rheumatology Offers Safe and Quality Care in the Management of Juvenile Idiopathic Arthritis-Comparing Key Performance Indicators with the PR-COIN RegistryJulie Herrington, Patrick Clarkin, Jade Singleton, et al.
The Journal of Rheumatology|November 15, 2025
Evaluation of Health Disparities in Outcomes of Patients With Juvenile Idiopathic ArthritisJulia G Harris, Jade H Singleton, Tracy V Ting, et al.
ACR Open Rheumatology|October 8, 2025
Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal TrialNicolino Ruperto, Daniel J Lovell, Olga Synoverska, et al.
Arthritis Care & Research|June 12, 2023
Pediatric Rheumatology Care and Outcomes Improvement Network's Quality Measure Set to Improve Care of Children With Juvenile Idiopathic ArthritisCatherine A Bingham, Julia G Harris, Tingting Qiu, et al.
Frontiers in Pediatrics|August 19, 2024
Using a collaborative learning health system approach to improve disease activity outcomes in children with juvenile idiopathic arthritis in the Pediatric Rheumatology Care and Outcomes Improvement NetworkJulia G Harris, Catherine A Bingham, Sheetal S Vora, et al.
Lancet (London, England)|November 12, 2021
Tofacitinib in juvenile idiopathic arthritis: a double-blind, placebo-controlled, withdrawal phase 3 randomised trialNicolino Ruperto, Hermine I Brunner, Olga Synoverska, et al.
Arthritis Care & Research|November 8, 2017
Consensus Treatment Plans for Chronic Nonbacterial Osteomyelitis Refractory to Nonsteroidal Antiinflammatory Drugs and/or With Active Spinal LesionsYongdong Zhao, Eveline Y Wu, Melissa S Oliver, et al.
Pediatric Rheumatology Online Journal|February 8, 2022
Translating research into practice-implementation recommendations for pediatric rheumatology; Proceedings of the childhood arthritis and rheumatology research alliance 2020 implementation science retreatCagri Yildirim-Toruner, Rajdeep Pooni, Y Ingrid Goh, et al.
Pageof 2